News
Technology Development Board approves financial support to MyLab to scale-up production of COVID-19 diagnostic kits
Mylab Discovery Solutions is the first indigenous company to develop real-time PCR based molecular diagnostic kit that screens and detects COVID-19
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease
3 Biotech companies, Serum Institute, Bharat Biotech & Cadila to get DBT funds for COVID-19 vaccine development
DBT secretary Dr Renu Swarup said the government is taking a multifaceted approach to ensure that vaccine companies utilizing different platforms and at different stages of development are fast tracked through a research consortium under funding from the National Biopharma Mission, an initiative launched in 2017 to support development of vaccines and drugs.
.jpg)
COVID19: Why diagnostics? : Some thoughts on "Why testing?" in this Covid19 crisis and the purposes it could serve
I thought I will use this blog to put down some useful purposes that testing can serve. (A disclaimer — there different types of diagnostic tests which answer different questions; so, please do not assume that every test does the same thing. Also different tests will have different levels of certainty with which they give results.)”
Archives
India Biotech Handbook 2024
